User profiles for Benjamin Blyth

Benjamin Blyth

Peter MacCallum Cancer Centre
Verified email at petermac.org
Cited by 1178

[HTML][HTML] The PP2A-Integrator-CDK9 axis fine-tunes transcription and can be targeted therapeutically in cancer

…, I Todorovski, CJ Kearney, JJ Sandow, Z Fan, B Blyth… - Cell, 2021 - cell.com
Gene expression by RNA polymerase II (RNAPII) is tightly controlled by cyclin-dependent
kinases (CDKs) at discrete checkpoints during the transcription cycle. The pausing checkpoint …

Radiation-induced bystander effects: what are they, and how relevant are they to human radiation exposures?

BJ Blyth, PJ Sykes - Radiation research, 2011 - meridian.allenpress.com
The term radiation-induced bystander effect is used to describe radiation-induced biological
changes that manifest in unirradiated cells remaining within an irradiated cell population. …

Inhibition of METTL3 results in a cell-intrinsic interferon response that enhances antitumor immunity

…, L MacPherson, EN Wainwright, B Liddicoat, BJ Blyth… - Cancer Discovery, 2023 - AACR
This work demonstrates that METTL3 inhibition stimulates a cell-intrinsic interferon response
through dsRNA formation. This immunomodulatory mechanism is distinct from current …

[HTML][HTML] Copper-67-labeled bombesin peptide for targeted radionuclide therapy of prostate cancer

…, EM van Dam, S Sreekumar, C Mpoy, BJ Blyth… - Pharmaceuticals, 2022 - mdpi.com
The gastrin-releasing peptide receptor (GRPR) is a promising molecular target for imaging
and therapy of prostate cancer using bombesin peptides that bind to the receptor with high …

[HTML][HTML] Imaging immunity in patients with cancer using positron emission tomography

…, JA Trapani, T John, P Donnelly, B Blyth… - NPJ precision …, 2022 - nature.com
Immune checkpoint inhibitors and related molecules can achieve tumour regression, and
even prolonged survival, for a subset of cancer patients with an otherwise dire prognosis. …

[HTML][HTML] A deep learning model to automate skeletal muscle area measurement on computed tomography images

…, P Jackson, C Litchfield, L Denehy, BJ Blyth… - Frontiers in …, 2021 - frontiersin.org
Background Muscle wasting (Sarcopenia) is associated with poor outcomes in cancer patients.
Early identification of sarcopenia can facilitate nutritional and exercise intervention. Cross…

Radiation therapy-induced metastasis: radiobiology and clinical implications

BJ Blyth, AJ Cole, MP MacManus, OA Martin - Clinical & experimental …, 2018 - Springer
Radiation therapy is an effective means of achieving local control in a wide range of primary
tumours, with the reduction in the size of the tumour(s) thought to mediate the observed …

Potential screening assays for individual radiation sensitivity and susceptibility and their current validation state

M Gomolka, B Blyth, M Bourguignon… - … Journal of Radiation …, 2020 - Taylor & Francis
Purpose: The workshop on ‘Individual Radiosensitivity and Radiosusceptibility’ organized by
MELODI and CONCERT on Malta in 2018, evaluated the current state of assays to identify …

[HTML][HTML] Clinical and functional assays of radiosensitivity and radiation-induced second cancer

…, E Kyriakou, T Kron, OA Martin, BJ Blyth - Cancers, 2017 - mdpi.com
Whilst the near instantaneous physical interaction of radiation energy with living cells leaves
little opportunity for inter-individual variation in the initial yield of DNA damage, all the …

[HTML][HTML] A genome-wide CRISPR/Cas9 screen identifies DNA-PK as a sensitiser to 177Lutetium-DOTA-octreotate radionuclide therapy

…, T Gulati, KJ Simpson, RW Tothill, B Blyth… - Theranostics, 2023 - ncbi.nlm.nih.gov
Peptide receptor radionuclide therapy (PRRT) using 177 Lutetium-DOTA-octreotate (LuTate)
for neuroendocrine tumours (NET) is now an approved treatment available in many …